A fully-loaded product pipeline in various stages of clinical development, Nobel Prize-winning advisors, partnerships with Harvard, Oxford, and MIT — and much more. At the heart of each one of our initiatives is a commitment to rigorous scientific research.
Our current pipeline includes preclinical and clinical trials for skin, microbiome, muscle, cognition, and circadian rhythm. While we're enthusiastic about these developments, there’s of course no guarantee that any of these trials will yield a positive result.
Beyond Basis, we are working with our scientific advisors and university partners to identify promising new research and innovative compounds. These compounds are all tested for safety and efficacy in placebo-controlled human trials before coming to market.
As you can see from our current research pipeline (pictured below), there’s a lot happening behind the scenes at Elysium — and a lot to look forward to.